| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $20.1M | +17.5% |
| R&D Expense | $798K | -93.0% |
| SG&A Expense | $11.2M | +96.3% |
| Operating Income | -$5.6M | -116.0% |
| Interest Expense | $18.6M | +81.0% |
| Pre-tax Income | -$53.6M | -7679.2% |
| Income Tax | $15K | -97.7% |
| Net Income | -$69.5M | — |
| EPS (Basic) | -$0.93 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.6M | +632.5% |
| Accounts Receivable | $651K | -80.5% |
| Current Assets | $115.0M | -51.4% |
| Total Assets | $185.3M | -21.7% |
| Current Liabilities | $247.1M | +3043.7% |
| Total Liabilities | $248.5M | +3062.1% |
| Stockholders' Equity | -$63.3M | -813.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Capital Expenditures | $4.7M | +310.5% |
| -190.6% |
| EPS (Diluted) | -$0.93 | -190.6% |